DACTINOMYCIN
Active substance: dactinomycin
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DACTINOMYCIN .5 mg/mL
United StatesActive
Marketing holder: Eugia US LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- DACTINOMYCIN · .5 mg/mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 6 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e39-7adb-b91d-927112a928bf,01a120c3-2e75-7ad5-8ec3-14c1c7e377ae,01a120c3-6b9e-76c2-b2ac-787ebaf0d72e,01a120c3-d807-79b6-9f07-feea33f5fa2e,01a120c6-7946-7711-8f85-5ab97817206d;count=5 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-772f-712a-b875-0295f3f741b7,01a1208e-7734-72ad-a28f-e16a5dd4dcdf,01a1208f-a4b3-7294-8286-88ccea03bdbf,01a12098-63e7-77d1-a1ce-23589269b575,01a1209e-4d92-73a3-ad77-2d19b0f651c4;count=5 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 55150-431
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
- product · openFDA NDC · 55150-431 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 55150-431 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 55150-431 · Verified 2026-10-09 · open in source